Indo US Bio-Tech standalone net profit rises 37.23% in the December 2024 quarter
Sales rise 6.56% to Rs 23.56 crore
Net profit of Indo US Bio-Tech rose 37.23% to Rs 5.05 crore in the quarter ended December 2024 as against Rs 3.68 crore during the previous quarter ended December 2023. Sales rose 6.56% to Rs 23.56 crore in the quarter ended December 2024 as against Rs 22.11 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales23.5622.11 7 OPM %23.4719.13 -PBDT5.173.94 31 PBT5.013.75 34 NP5.053.68 37Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content